Industry Symposia

Industry sponsored symposia

Takeda UK Ltd.

Industry Symposia
7 May 2021 | 12:00 - 13:30 | virtual hall 1

Treatment strategies for ADHD

Chair: Peter Mason, UK

001 | Psychopharmacology of ADHD medications 

Speaker: 
Andrew Jay, UK 

002 | Ask the experts: What’s the difference? (moderated Q&A)

Discussants: 
Caroline Bleakley, UK 
Willem Bohlmeijer, The Netherlands 
Lotta Borg Skoglund, Sweden 
Andrew Jay, UK 
Roger McIntyre, Canada

003 | Utilising a choice of ADHD medications in clinical practice 

Speaker:
Peter Mason, UK 

004 | Ask the experts: How to optimise ADHD treatment for patients with ADHD (moderated Q&A)

Discussants: 
Caroline Bleakley, UK 
Willem Bohlmeijer, The Netherlands 
Lotta Borg Skoglund, Sweden 
Andrew Jay, UK 
Roger McIntyre, Canada

005 | Closing comments 

Information in this symposium is for healthcare professionals outside of US only. Takeda medicines will be discussed at this symposium. Some of the medicines discussed in this symposium may not be available/licensed for ADHD in some countries. Clinicians should refer to the respective Summary of Product Characteristics (SmPC) in their country before prescribing. Prescribing information for Takeda products will be available at Takeda’s symposium and exhibition booth at this congress.

MEDICE Arzneimittel Pütter GmbH & Co. KG

Industry Symposia
7 May 2021 | 18:30 - 19:30 | virtual hall 1

ADHD – The Patient’s Perspective

Moderator: Dora Wynchank, The Netherlands

001 | Diagnosis and Treatment of ADHD in Europe, Survey 2020

Speaker:
Carola Stivala, Malta

002 | A million miles an hour - a day in the life of an ADHD patient

Speaker:
Kobus van Rensburg, UK

003 | Questions & Discussion